Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025

SELL
N/A
-2,400,000 Closed
0 $0
Q3 2023

Feb 13, 2025

BUY
$21.54 - $24.41 $51.7 Million - $58.6 Million
2,400,000 New
2,400,000 $54.3 Million

Others Institutions Holding ABCM

About Abcam plc


  • Ticker ABCM
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 229,044,992
  • Description
  • Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. Its principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex and multiplex immunoassays; proteins and peptides that include...
More about ABCM
Track This Portfolio

Track Kite Lake Capital Management (Uk) LLP Portfolio

Follow Kite Lake Capital Management (Uk) LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kite Lake Capital Management (Uk) LLP, based on Form 13F filings with the SEC.

News

Stay updated on Kite Lake Capital Management (Uk) LLP with notifications on news.